Vanguard Group Portfolio holdings
AUM $6.18T
1-Year Return
25.19%
The Vanguard Group, founded in 1975 by John C. Bogle, is one of the world's largest investment management companies, headquartered in Malvern, Pennsylvania. As of recent years, it manages trillions in assets, offering a wide range of mutual funds, ETFs, and retirement products, catering to both individual and institutional investors. Its philosophy emphasizes low fees, diversification, and a buy-and-hold strategy, making it a dominant player in the passive investing revolution.
This Quarter Return
+4.5%
1 Year Return
+25.19%
3 Year Return
+103.99%
5 Year Return
+190.29%
10 Year Return
+458.75%
AUM
$5.74T
AUM Growth
+$157B
(+2.8%)
Cap. Flow
+$58.3B
Cap. Flow
% of AUM
1.01%
Top 10 Holdings %
Top 10 Hldgs %
29.07%
Holding
4,397
New
46
Increased
2,367
Reduced
1,397
Closed
104
Top Buys
| 1 |
Apple
AAPL
|
+$12.3B |
| 2 |
NVIDIA
NVDA
|
+$4.78B |
| 3 |
Microsoft
MSFT
|
+$4.4B |
| 4 |
Amazon
AMZN
|
+$3.87B |
| 5 |
Boeing
BA
|
+$2.24B |
Top Sells
| 1 |
Applovin
APP
|
+$2.15B |
| 2 |
MRO
Marathon Oil Corporation
MRO
|
+$1.81B |
| 3 |
Palantir
PLTR
|
+$1.71B |
| 4 |
Marvell Technology
MRVL
|
+$1.34B |
| 5 |
CTLT
CATALENT, INC.
CTLT
|
+$1.23B |
Sector Composition
| 1 | Technology | 30.54% |
| 2 | Financials | 13.56% |
| 3 | Consumer Discretionary | 10.93% |
| 4 | Healthcare | 9.99% |
| 5 | Industrials | 8.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3176
MoonLake Immunotherapeutics
MLTX
$3.38B
| $6.25M | ﹤0.01% |
115,416
-2,320
| -2% | -$126K |
|
3177
Atossa Therapeutics
ATOS
$107M
| $6.25M | ﹤0.01% |
6,618,969
+20,673
| +0.3% | +$19.5K |
|
3178
ThredUp
TDUP
$1.26B
| $6.25M | ﹤0.01% |
4,493,423
+77,659
| +2% | +$108K |
|
3179
Achieve Life Sciences
ACHV
$151M
| $6.16M | ﹤0.01% |
1,749,791
-190,597
| -10% | -$671K |
|
3180
Reservoir Media
RSVR
$511M
| $6.14M | ﹤0.01% |
678,129
+83,535
| +14% | +$756K |
|
3181
Townsquare Media
TSQ
$114M
| $6.14M | ﹤0.01% |
675,016
+2,655
| +0.4% | +$24.1K |
|
3182
Fennec Pharmaceuticals
FENC
$241M
| $6.13M | ﹤0.01% |
969,754
-78,137
| -7% | -$494K |
|
3183
Alico
ALCO
$257M
| $6.11M | ﹤0.01% |
235,530
+55,757
| +31% | +$1.45M |
|
3184
MainStreet Bancshares
MNSB
$163M
| $6.1M | ﹤0.01% |
337,099
| – | – |
|
3185
Hanover Bancorp
HNVR
$161M
| $6.1M | ﹤0.01% |
264,490
+169,544
| +179% | +$3.91M |
|
3186
Pro-Dex
PDEX
$110M
| $6.09M | ﹤0.01% |
130,345
+9,218
| +8% | +$431K |
|
|
OKUR
3187
OnKure Therapeutics, Inc. Class A Common Stock
OKUR
$32.3M
| $6.08M | ﹤0.01% |
706,733
+618,523
| +701% | +$5.32M |
|
|
CKPT
3188
DELISTED
Checkpoint Therapeutics
CKPT
| $6.07M | ﹤0.01% |
1,897,433
+523,127
| +38% | +$1.67M |
|
3189
Douglas Elliman
DOUG
$257M
| $6.06M | ﹤0.01% |
3,630,107
-31,924
| -0.9% | -$53.3K |
|
|
RPT
3190
Rithm Property Trust Inc.
RPT
$119M
| $6.04M | ﹤0.01% |
2,035,277
+39,755
| +2% | +$118K |
|
3191
Quest Resource Holding
QRHC
$32.5M
| $6.04M | ﹤0.01% |
929,723
+3,707
| +0.4% | +$24.1K |
|
3192
X4 Pharmaceuticals
XFOR
$68.2M
| $6.02M | ﹤0.01% |
273,363
-7,995
| -3% | -$176K |
|
3193
Soho House & Co
SHCO
$1.73B
| $6M | ﹤0.01% |
805,386
-1,101
| -0.1% | -$8.2K |
|
3194
Ondas Holdings
ONDS
$1.99B
| $6M | ﹤0.01% |
2,342,387
+256,866
| +12% | +$658K |
|
3195
Affinity Bancshares
AFBI
$124M
| $6M | ﹤0.01% |
342,652
+34,872
| +11% | +$610K |
|
3196
Everspin Technologies
MRAM
$176M
| $5.98M | ﹤0.01% |
936,524
-15,057
| -2% | -$96.2K |
|
3197
Epsilon Energy
EPSN
$117M
| $5.97M | ﹤0.01% |
961,694
| – | – |
|
3198
Advantage Solutions
ADV
$606M
| $5.97M | ﹤0.01% |
2,043,962
+13,303
| +0.7% | +$38.8K |
|
3199
VistaGen Therapeutics
VTGN
$89M
| $5.96M | ﹤0.01% |
2,020,351
+227,185
| +13% | +$670K |
|
3200
Sight Sciences
SGHT
$183M
| $5.95M | ﹤0.01% |
1,633,929
-56,818
| -3% | -$207K |
|